Efficacy and safety of radiation therapy in advanced adrenocortical carcinoma (ACC)
dc.contributor.author | Kimpel, O | |
dc.contributor.author | Paul, S | |
dc.contributor.author | Bülent, P | |
dc.contributor.author | Megerle, F | |
dc.contributor.author | Haak, HR | |
dc.contributor.author | Pittaway, J | |
dc.contributor.author | Quinkler, M | |
dc.contributor.author | Matthias, K | |
dc.contributor.author | Fassnacht, M | |
dc.date.accessioned | 2021-06-07T17:18:58Z | |
dc.date.available | 2021-06-07T17:18:58Z | |
dc.date.issued | 2021-05-15 | |
dc.identifier.issn | 1470-3947 | |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/72366 | |
dc.relation.ispartof | Endocrine Abstracts | |
dc.title | Efficacy and safety of radiation therapy in advanced adrenocortical carcinoma (ACC) | en_US |
dc.type | Conference Proceeding | en_US |
dc.identifier.doi | 10.1530/endoabs.73.oc11.3 | |
pubs.notes | Not known | en_US |
rioxxterms.funder | Default funder | en_US |
rioxxterms.identifier.project | Default project | en_US |
qmul.funder | Investigating the role of the Notch atypical ligand delta-like homologue 1 (DLK1) in adrenocortical carcinoma::Medical Research Council | en_US |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |
This item appears in the following Collection(s)
-
Centre for Endocrinology [560]